Complement C2 Activity Assay

Creative Biolabs provides reliable and customizable complement C2 activity assay services for academic laboratories, biotechnology companies, pharmaceutical developers, and translational research groups. Our service is designed to help clients measure the functional performance of C2 in human or animal samples, investigate complement-related disease mechanisms, and support drug discovery programs targeting classical or lectin pathway activation.

Submit Your Request Now

Download our service brochure

Inquiry

What is a Complement C2 Activity Assay?

A complement C2 activity assay is a laboratory test designed to evaluate the functional contribution of C2 to complement activation. Depending on project requirements, this assay can be used to determine whether C2 in a sample is present, active, depleted, inhibited, restored, consumed, or altered under specific experimental conditions.

The assay may be configured as a hemolytic assay, ELISA-based assay, pathway-specific functional assay, reconstitution assay, inhibitor screening assay, or customized format based on client needs. In a typical functional setting, C2 activity can be evaluated by measuring the ability of a test sample or purified C2 preparation to support classical pathway-mediated complement activation. When C2 activity is sufficient, downstream events such as C3 convertase formation, C3 cleavage, C3b deposition, C5 convertase formation, terminal complement complex generation, or complement-mediated lysis can occur. When C2 is deficient, inhibited, consumed, or functionally impaired, these downstream readouts are reduced or absent.

Creative Biolabs offers flexible C2 activity assay solutions suitable for serum, plasma, purified proteins, recombinant C2 variants, biological fluids, cell culture supernatants, animal model samples, drug-treated samples, and customized experimental matrices. Our experienced scientists can help select the proper assay type according to your sample format, expected activity range, research objective, required sensitivity, species origin, and downstream data application.

Great Minds Choose Creative Biolabs

Partner with Us

Creative Biolabs' Complement C2 Activity Assay Services

Creative Biolabs provides a full range of complement C2 activity assay services to meet diverse needs in basic research, translational studies, disease model validation, complement drug discovery, and preclinical evaluation. Our services are not limited to one fixed protocol. Instead, we develop customized testing strategies based on sample type, project purpose, assay endpoint, analytical sensitivity, and data reporting requirements.

C2 Functional Activity Test

Our C2 functional activity test evaluates whether C2 in a test sample can participate in complement activation. This service is suitable for serum samples, plasma samples, purified C2 preparations, recombinant C2 proteins, and experimental systems in which C2 activity needs to be compared across groups.

C2 Hemolytic Activity Assay

Creative Biolabs can design C2-dependent hemolytic assays using sensitized erythrocyte systems, C2-depleted matrices, complement reconstitution formats, and appropriate controls. This type of assay is useful for determining functional C2 activity in biologically relevant cascade conditions.

C2 Reconstitution Assay

For projects involving purified proteins, recombinant variants, or functional rescue experiments, Creative Biolabs provides C2 reconstitution assays. In this format, C2-deficient or C2-depleted serum systems can be supplemented with test C2 preparations to evaluate restoration of complement activity.

Classical Pathway C2 Activity Analysis

Depending on the project, downstream endpoints may include hemolysis, C3b deposition, C4b2a formation, C3a generation, C5b-9 deposition, or pathway-specific ELISA signals. This service can help researchers understand whether observed complement changes are associated with C2-dependent classical pathway activation.

Lectin Pathway-Associated C2 Activity Analysis

Creative Biolabs can assist in designing experiments to evaluate C2-related activity in lectin pathway activation models. This is useful for researchers investigating microbial recognition, carbohydrate-triggered complement activation, mannose-binding lectin pathway function, ficolin-associated activation, or lectin pathway-directed therapeutic candidates.

C2 Inhibitor Screening and Validation

Creative Biolabs supports inhibitor screening and validation by measuring the ability of test molecules to suppress C2 cleavage, C4b2a formation, C3 activation, C3b deposition, hemolysis, or downstream terminal pathway activation. Our customized assay systems can be configured for antibodies, peptides, aptamers, small molecules, proteins, fusion molecules, biologics, and other candidate formats.

C2 Activity in Disease Model Samples

Creative Biolabs provides C2 activity testing for disease model samples, including serum, plasma, tissue homogenates, cell culture supernatants, and animal model samples. We can support comparative studies across treatment groups, disease stages, time points, genetic backgrounds, or intervention strategies.

C2 Activity and Complement Consumption Analysis

Creative Biolabs can integrate C2 activity testing with additional complement readouts such as CH50, C4, C3, C3a, C5a, sC5b-9, C4d, C3b deposition, or C1 complex activity to help clients interpret whether C2-related changes indicate upstream defects, pathway consumption, or downstream activation.

Discuss Your Needs

Available Assay Platforms

Creative Biolabs has established multiple complement assay platforms that can be adapted for complement C2 activity assay development. The appropriate assay format will be selected according to sample properties, expected activity level, throughput needs, required endpoint, and project stage.

Hemolytic Assay Platform

ELISA-Based Assay Platform

Deposition Assay Platform

Cell-Based Complement Activity Assays

Service Workflow

Creative Biolabs follows a systematic workflow to ensure that every complement C2 activity assay project is designed appropriately and executed efficiently.

Complement C2 assay. (Creative Biolabs Original) Fig. 1 Workflow of complement C2 functional test.

Design Your Workflow

Suggested C2 Activity Assay Panels

To help clients select the right testing plan, Creative Biolabs can provide several recommended panel options.

Basic C2 Functional Activity Panel

This panel is suitable for routine functional assessment of C2 activity in serum, plasma, or purified protein samples. It may include C2-dependent functional readout, positive and negative controls, reference sample comparison, and activity normalization.

C2 Deficiency Investigation Panel

This panel is designed to investigate whether reduced complement activity is related to C2 deficiency or functional impairment. It may include C2 activity, CH50, C4, C3, C2 protein measurement, and C2 reconstitution analysis.

C2 Inhibitor Validation Panel

This panel is suitable for evaluating candidate molecules that suppress C2-dependent complement activation. It may include dose-response testing, IC50 calculation, hemolytic readout, C3b deposition, C5b-9 formation, and specificity comparison against other complement pathways.

C2 Pathway Mechanism Panel

This panel helps researchers understand pathway-level changes. It may include C1q binding, C1 complex activity, C4 activation, C2 activity, C3 convertase-related readouts, C3a, C5a, and sC5b-9 measurement.

Customization

Creative Biolabs understands that complement research projects often involve unique experimental designs. Standard assays may not fully address specialized questions, especially in drug discovery, rare disease research, engineered protein evaluation, or non-human model systems. Therefore, we offer customized complement C2 activity assay development for clients who require tailored conditions, special sample matrices, non-standard species, unique inhibitors, or integrated readout systems.

Customization Category	Descriptions
Assay Format Selection	Selection of hemolytic, ELISA, deposition, or cell-based assay formats
Species Adaptation	Human or animal sample adaptation
Reconstitution Systems	C2-depleted serum reconstitution systems
Recombinant Protein Evaluation	Recombinant C2 activity comparison
Inhibitor Assessment	Dose-response inhibitor testing
Pathway-Specific Design	Pathway-specific activation conditions
Multiplex Analysis	Multiplex complement marker measurement
Parallel Functional Testing	Parallel CH50 or pathway activity testing
Integrated Complement Readouts	Integration with C3/C4/C5 activation readouts
Reporting Customization	Customized reporting format

Design Your Customization

Case Studies

Case 1

Multiplex immunoassays and ELISA were used to quantify a panel of complement components (C1Q, C2, C3, C4, C5, Factor B, Factor H, MBL, and properdin) and activation products (C4b, C3b, C5a, and C5b-9), of classical, alternative and lectin pathways

Complement components of the classical, alternative and lectin pathways were analyzed in plasma from AChR-MG patients, MuSK-MG patients, and healthy controls. The following proteins were included: C1q, C2, C3, C4, C5, Factor B, Factor H, Mannose-Binding Lectin (MBL), and properdin. Bead-based multiplex immunoassays were used for all the complement cascade proteins except for C2 and Properdin, which were independently analyzed by ELISA.

Complement C2 assay. (Creative Biolabs Original) Fig. 2 C2 levels were estimated by a specific ELISA.^1,2

References

Iacomino, Nicola, et al. "Complement activation profile in myasthenia gravis patients: perspectives for tailoring anti-complement therapy." Biomedicines 10.6 (2022): 1360. https://doi.org/10.3390/biomedicines10061360
Distributed under Open Access license CC BY 4.0, without modification.

What Our Clients Say

"Creative Biolabs helped us evaluate C2-dependent classical pathway activity in a challenging serum sample set. Their team provided useful recommendations for sample handling, dilution design, and control selection before the study began. The final data package was clear, well-organized, and highly informative for our follow-up complement pathway analysis."

— Research Scientist, Immunology Research Institute

"We needed a customized assay to compare several early-stage complement inhibitor candidates. Creative Biolabs developed a C2-dependent functional readout and helped us evaluate dose-response behavior across multiple molecules. Their scientific team was responsive throughout the project and provided practical input on how to interpret partial inhibition patterns."

— Director of Discovery Biology, Biotechnology Company

"Our project required functional comparison of several recombinant C2 variants. The Creative Biolabs team established a reconstitution-based assay and generated results that allowed us to rank the variants according to activity recovery. The report also included helpful notes on assay limitations and recommended next steps."

— Protein Engineering Lead, Biopharmaceutical Company

"Our initial question focused on C2 activity, but Creative Biolabs suggested adding C4, C3 activation, and terminal pathway readouts. This broader panel helped us understand that the observed signal was not limited to C2 alone, but reflected a coordinated change in classical pathway activation."

— Senior Scientist, Autoimmune Disease Research Group

Frequently Asked Questions

Is C2 activity testing the same as C2 protein quantification?

No. C2 protein quantification measures the amount of C2 protein present in a sample, while C2 activity testing evaluates whether that C2 is functionally active. A sample may contain measurable C2 protein but show reduced activity because of mutation, degradation, improper processing, inhibitor binding, autoantibodies, complement consumption, or unfavorable storage conditions. For functional pathway studies, C2 activity testing often provides more biologically relevant information than concentration measurement alone.

What types of samples can be tested?

Creative Biolabs can support C2 activity testing using a wide range of sample types, including human serum, human plasma, animal serum, animal plasma, purified C2 protein, recombinant C2 protein, C2 variants, C2-depleted serum systems, biological fluids, cell culture supernatants, tissue homogenates, disease model samples, preclinical samples, and customized biological matrices. Final sample compatibility depends on the assay format, species, matrix background, sample volume, and expected activity level.

Can C2 activity testing be combined with CH50?

Yes. Combining C2 activity testing with CH50 can be highly useful. CH50 provides an overview of classical pathway functional capacity, while C2 activity testing helps determine whether C2 contributes to any observed defect. Additional assays such as C4, C3, C3a, C5a, sC5b-9, C1q binding, or C3b deposition can further clarify the pathway mechanism.

Can C2 activity testing be used for complement inhibitor screening?

Yes. Complement C2 activity assay formats can be adapted for inhibitor screening and validation. Candidate molecules may be evaluated for their ability to reduce C2-dependent complement activation, inhibit C3 convertase formation, suppress downstream C3b deposition, block hemolysis, or reduce terminal complement complex generation. Dose-response testing, IC50 calculation, and comparison with control inhibitors can also be included.

Which assay format should I choose?

If the goal is to measure integrated classical pathway function, a hemolytic assay may be suitable. If the goal is to measure downstream complement activation products, an ELISA-based or deposition assay may be preferred. If the goal is to evaluate recombinant C2 or C2 variants, a reconstitution assay may be appropriate. If the goal is to evaluate inhibitors, a dose-response functional assay with pathway-specific controls is recommended. Creative Biolabs can help select the optimal format after reviewing your project requirements.

How much sample is required?

The required sample volume depends on the assay format, number of replicates, dilution scheme, control design, and whether repeat or confirmatory testing is needed. Small-volume testing may be possible for some assays, while multi-readout or dose-response studies may require more material. Creative Biolabs will provide project-specific sample volume recommendations during the consultation stage.